| Lastest Insider Transactions Of Verve Therapeutics, Inc. ( VERV ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| VERV | Verve Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | 2024-11-29 | Sell | 555 | 5.64 | 3,130 | 2024-12-03 16:30:04 |
| VERV | Verve Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | 2024-11-29 | Option Exercise | 1,875 | 0.00 | 0 | 2024-12-03 16:30:04 |
| VERV | Verve Therapeutics, Inc. | Kathiresan Sekar | Chief Executive Officer | 2024-06-28 | Option Exercise | 30,000 | 2.87 | 86,100 | 2024-07-02 07:30:03 |
| VERV | Verve Therapeutics, Inc. | Ashe Andrew D. | See Remarks | 2024-05-14 | Buy | 76,000 | 6.26 | 475,760 | 2024-05-15 17:30:07 |
| VERV | Verve Therapeutics, Inc. | Nickerson Joan | Chief Administrative Officer | 2024-04-01 | Sell | 1,514 | 8.24 | 12,475 | 2024-04-03 17:00:05 |
| VERV | Verve Therapeutics, Inc. | Nickerson Joan | Chief Administrative Officer | 2024-04-01 | Option Exercise | 3,315 | 0.00 | 0 | 2024-04-03 17:00:05 |
| VERV | Verve Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | 2023-11-29 | Sell | 554 | 11.45 | 6,343 | 2023-12-01 16:30:05 |
| VERV | Verve Therapeutics, Inc. | Dorval Allison | Chief Financial Officer | 2023-11-29 | Option Exercise | 1,875 | 0.00 | 0 | 2023-12-01 16:30:05 |
| VERV | Verve Therapeutics, Inc. | Bellinger Andrew | CSO & CMO | 2022-12-14 | Option Exercise | 36,000 | 2.87 | 103,320 | 2022-12-16 17:00:34 |
